Hepatitis C virus infection is frequently associated with high titers of anti-thyroid antibodies

International Journal of Immunopathology and Pharmacology

Volumn 12, Issue 3, 1999, Pages 121-126

  Ploix, C ^a   Veber, S ^a   Chevallier Queyron, P ^b   Ritter, J ^b   Bousset, G ^a   Monier, J C ^a   Fabien, N ^a  

^a Laboratoire d'Immunologie   (France)

^b Laboratoire d'Hygiène   (France)

Author keywords

Autoimmunity; Hepatitis C virus; IFN ; Thyroid antibodies

Indexed keywords

AUTOANTIBODY; MICROSOME ANTIBODY; THYROID ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

EID: 0032757611     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Paggi A., Leri O., Taliani G., DiPrima A.M., Pellegrino C., Farralli A.R. et al. 1995. Hepatitis C virus and autoimmune thyroid diseases: possible non coincidental association. Eur. J. Internal Medicine 6: 33
2. Metcalfe R.A., G. Ball, G. Kudesia and A.P. Weetman. 1997. Failure to find an association between hepatitis C virus and thyroid auto-immunity. Thyroid 7: 421
3. Marcellin P., M. Pouteau, E. Baudin, N. Colas-Linhart, F. Dogos, S. Erlinger et al. 1991. Thyroid dysfunction induced by recombinant alpha interferon in patients with chronic hepatitis C: a prospective study. Hepatol. 14: 77
4. Pittau E., A. Bogliolo, A. Tinti, Q. Mela, G. Ibba and G. Salis. 1997. Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C. Clin. Exp. Rheum. 15: 415
5. Pateron D., I. Augier, J.C. Duclos-Vallé, H. Jouanolle, D.J. Hartmann and M. Beaugrand. 1991. High prevalence of abnormal thyroid tests in patients with chronic hepatitis C (CHC) before alpha Interferon (IFN) therapy : relation with IFN induced thyroid dysfunction. Hepatol. 14: 77
6. Tran A., J.F. Quantara, C. Beusnel, V. Thiers, M. De Sourza, E. François et al. 1992. Hepatitis C virus and Hashimotoís thyroiditis. Eur. J. Med 1: 116
7. Pateron D., D.J. Hartmann, J.C. Duclos-VallÈe, H. Jouanolle and M. Beaugrand. 1992. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J. Hepatol. 16: 244
8. Hadziyannis S.J. 1996. Nonhepatic manifestations and combined diseases in HCV infection. Digestive diseases and Sciences 1: 63
9. Tran A., J.F. Quantara, S. Benzaken, V. Thiers, H.T. Chau, P. Hastier P. et al. 1993. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatol. 18: 253
10. Boadas J., Rodriguez-Espinosa J., Enriquez J., Miralles F., Martinez-Cerezo F.J., Gonzalez P. et al. 1995. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J. Hepatol. 22: 614
11. Marazuella M., L. Garcia-Buey, B. Gonzalez-Fernandez, C. Garcia-Monzon, A. Arranz, M.J. Borque, R. Moreno-Otero. 1996. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin. Endocrinol. 44: 635
12. Preziati D., L. La Rosa, G. Covini, R. Marcelli, S. Rescalli, L. Persani, E. Del Ninno, P.L. Meroni, M. Colombo and P. Beck-Peccoz. 1995. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a, Eur. J. Endocrinol. 132: 587
13. Marcellin P., M. Pouteau and J.P. Benhamou. 1995. Hepatitis C virus infection, aIFN therapy and thyroid dysfunction. J. Hepatol. 22: 364
14. Pawlotsky J.M., M. Ben Yahia, C. André C. et al. 1994. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study, Hepatology 19: 841
15. Bornet H., A.M. Madec, P. Rodien et al. 1990. Evaluation of anti-TPO antibody determination in various clinical situations, In: Carayon P, Ruf J, eds, Thyroperoxydase and thyroid autoimmunity, London: Colloque INSERM / John Libbey Eurotext Ltd, p. 297
16. Bayraktar Y., M. Bayraktar, A. Gurakar, T.I. Hassanein and D. Van Thiel. 1997. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with auto-immune hepatitis: the role of interferon in the development of auto-immune diseases. Hepato-gastroenterol. 44: 417